Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
AbCellera Biologics
ABCL
$3.29B
| $7.29M | 0.01% |
2,486,893
-459,810
| -16% | -$1.28M |
|
1202
Douglas Elliman
DOUG
$178M
| $7.28M | 0.01% |
4,361,804
+461,093
| +12% | +$887K |
|
1203
Post Holdings
POST
$3.64B
| $7.28M | 0.01% |
63,600
-125,800
| -66% | -$14.3M |
|
1204
Dentsply Sirona
XRAY
$2.35B
| $7.28M | 0.01% |
383,353
-226,605
| -37% | -$4.79M |
|
1205
BlackRock US Equity Factor Rotation ETF
DYNF
$40.4B
| $7.27M | 0.01% |
141,900
+75,200
| +113% | +$3.87M |
|
1206
Vanguard Russell 1000 Growth ETF
VONG
$46.1B
| $7.27M | 0.01% |
+70,400
| New | +$7.13M |
|
1207
Lemonade
LMND
$4.11B
| $7.27M | 0.01% |
+198,187
| New | +$6.33M |
|
1208
Akebia Therapeutics
AKBA
$240M
| $7.26M | 0.01% |
3,823,527
+105,727
| +3% | +$184K |
|
1209
Performance Food Group
PFGC
$16.7B
| $7.24M | 0.01% |
85,607
-28,600
| -25% | -$2.41M |
|
1210
Enel Chile
ENIC
$6.18B
| $7.24M | 0.01% |
2,512,771
+38,783
| +2% | +$108K |
|
1211
Paymentus
PAY
$5.25B
| $7.23M | 0.01% |
221,200
+136,100
| +160% | +$4.04M |
|
1212
Tidewater
TDW
$4.67B
| $7.2M | 0.01% |
+131,683
| New | +$7.5M |
|
|
FLIC
1213
DELISTED
First of Long Island Corp
FLIC
| $7.2M | 0.01% |
616,050
+21,200
| +4% | +$283K |
|
|
NOA
1214
North American Construction
NOA
$385M
| $7.19M | 0.01% |
332,800
-16,800
| -5% | -$329K |
|
1215
CubeSmart
CUBE
$9.4B
| $7.19M | 0.01% |
167,788
-19,600
| -10% | -$940K |
|
1216
Ionis Pharmaceuticals
IONS
$9.29B
| $7.18M | 0.01% |
205,514
+15,000
| +8% | +$561K |
|
1217
Hippo Holdings
HIPO
$874M
| $7.18M | 0.01% |
268,320
+127,716
| +91% | +$3.14M |
|
|
LTC
1218
LTC Properties
LTC
$2.18B
| $7.18M | 0.01% |
207,700
+85,000
| +69% | +$3.14M |
|
1219
Consolidated Water Co
CWCO
$504M
| $7.18M | 0.01% |
277,167
-14,200
| -5% | -$362K |
|
1220
KRONOS Worldwide
KRO
$967M
| $7.16M | 0.01% |
734,230
+31,830
| +5% | +$358K |
|
1221
Baytex Energy
BTE
$3.06B
| $7.15M | 0.01% |
2,770,800
+1,224,400
| +79% | +$3.48M |
|
1222
NRC Health Common Stock
NRC
$476M
| $7.14M | 0.01% |
404,886
+25,002
| +7% | +$474K |
|
1223
Viridian Therapeutics
VRDN
$2.46B
| $7.12M | 0.01% |
371,200
+311,600
| +523% | +$6.78M |
|
1224
Xeris Biopharma Holdings
XERS
$1.53B
| $7.12M | 0.01% |
2,098,840
+500,120
| +31% | +$1.61M |
|
|
SEI
1225
Solaris Energy Infrastructure
SEI
$4.15B
| $7.09M | 0.01% |
246,300
+5,100
| +2% | +$101K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.